| Tag | Content |
|---|
EnhancerAtlas ID | HS091-26717 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr2:86479190-86481220 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr2:86480269-86480279 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr2:86480269-86480279 | GGCACGTGCC | - | 6.02 | | Nr2f6(var.2) | MA0728.1 | chr2:86480188-86480203 | GAGGTCAAGAGTTCG | + | 6.24 | | SREBF2 | MA0596.1 | chr2:86479831-86479841 | ATCACCCCAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_54919 | chr2:86475833-86480091 | Stomach_Smooth_Muscle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTCCTGTCAA AGGAAAAACA GAGGCACACT GAGCTGGAAG GTTCAAACAC ATCTCTGTTT 60
TCTTTCCTTT CCTCTGAGCA TTGGGCTTGG CAGCTTGCCC AATCCTTGTT CTTGCTGGGC 120
CTGAAAAGCT GTAGGCACTT TGAAGGTGTG CGTGCAGAGG GGAGAGCAGA GATACAGGAG 180
AGTAGAAAAG GGAACTCTGA AAACACTGCA ACTTACGGAT CCAGCGATGC CCTGAGATTG 240
TTTCTAAAGC CCTCTGACCT TCCAGGAGGC TCCAGGAGGT TCTGGATATG GACAGCCTTG 300
CCTGCCATTC TACACACAGC CACTCACCAG ACACTGAAAG CACCCAGGGT GGAGAGAGTG 360
CCCAGAACCG AGCTTCTAGC CTCAGACCTG CCACCAACTG ACTGCCAGAC CTTGGCAAGC 420
CTCTCTACAC ACAGTTTTAG TCTTCTGAAA AACGAGGATA ATGATAATAC CCAACTTGCG 480
GAGCATGGTG AGGATTAAAT GAGGTAATTC CAGTAAAACA TCTAACACAG TGGCTAGTTT 540
CAATAAATGA TAACCATGTC ATCTTCCTTA TCTTGACAGG GTTGAGCCCT TGCAGTTCTA 600
AAATTCTGTT ATTCTATAGT TATTTAATTC TAAAATCAAA TATCACCCCA TTTGTATATC 660
GATGGGAGGG ATTACAAAGC TGAAAGAAAT GAGTATTACT GGATAAGGGA GATTGTTTTA 720
CACATATTCA AATAAAATCA GAAATTAGAA GTCATCCAGT GTCATGCAAC AAGGTAAAGG 780
TGAGATGGAA AACAGGATTG AGGTCTTCTT CAGGGACCAA AGCCAAGTAC AATATTGGTT 840
TAGTTCAAAT TTGGATTAAC TTTGGTGTAT TATTTTTGTT TGTTTGGGAG TGTTTTGTTG 900
TTGTCATTGT TTTAAGAAAA TGGCTGTTTG TCGGCCGGGT GCAGTGGCTC ACGCCTGTAA 960
TCCCAGCACT TTGGGAGGCC AAGGTGGGCG TATCACCTGA GGTCAAGAGT TCGAGACCAG 1020
CCTGGCCAAC ATGGTAAAAC CCCATCTCCT CTAAAAATAC AAAATGAGTC AGGCATGGTG 1080
GCACGTGCCT ATAGTCCCAG CTACCTGGGA GGCTGAGGCA GGAGAATTGC TGGAGCCCAG 1140
GAGGCAGAGG TTGCAGTGAG CCGAGATCGT GCCACTGCAC TCCAGCCTGG GCAACAGAGC 1200
AAGATTCCGC GCCCCCCACC CCCCAAAAAA AGGCTGTTTT TCATGACAGC TGCTCATTTC 1260
AGAGTTCGGT AAGACAATGA CATTTGGCCT TAGTCAAGTT CTGTGCATTA GTGTATTTCC 1320
ATTGCTTTGA GGTGTGCAAG TGGGTCAGCA ACCTCCTGCT GGATTCCCTG TGGAAGGCTT 1380
CCCCAGGAAG TCATAGCAGC AGGCCCTCTA ACTGTGACCT GCCTGTCCCC CACCACCACC 1440
CCTTTGGAAG TGATTCTTGG CAACTCTTAA GAGTCAGTCA CCTTCACTTC AATGGAAGTT 1500
ACATTGGCAG CTTCAGGGGA AGCCCAGCAT TTGGGGAAAG GGAAGTAAGA CGAGTAGGGA 1560
TTTGATAACC AGGTCAAGAC AGGGATCCGT TCCTCAAAAT CCACCCTTCT GAGACAGGAA 1620
GTGCTGCGGT CCGAGTTCCT AAAGAGATTT TCCGAAACTT GTACAGTAGC CTGCTCATCC 1680
AACGGATATG TTTCCCAAAG CCTTCCCCTT TCTAGTCCAA GGAATTCAAC TTTCAGAAAC 1740
AATAGACATT AATCTGTCAA GCCACCTATA ATGCTCCTAT TTTAGTTAAG AAACCCCACT 1800
ACACAATCAG CTTAGTAAGT AATACAGTTA ACGAATGATA CAATGTTGGA ATCGTTTGAC 1860
TTAATAATCC TGCTCTTGGG AATTAATTCT AAGACAATTA AAGGAAGCAA CTAAACTCCA 1920
GGAATGGTAG TGCTCACTGC AGAACTATCT ATATCAGGAA AAGGTAGAGA TAATCTAAAT 1980
ATCTAGCAGT AAGGGAACAT CATCATGGGT ATTACGAAGA CCAAGTAGAA 2030
|
